Perrigo | PRGO - Ordinary Share Capital


Perrigo reported $137.6M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
Bayer EUR 982.42M 0 Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
J&J USD 2.41B 584K Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Nestle CHF 2.53B 43.48M Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Reckitt Benckiser GBP 679.21M 605.21M Jun/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025
Zoetis USD 441.46M 2.48M Sep/2025